Iberdrola S.A. (0HIT)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 21.58 |
|---|---|
| 52-week range | 16.75 – 22.41 |
| Return, 1 month / 3 months | +7.4% / +3.3% |
| Return, 1 year / 3 years | +30.1% / +132.0% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 33.9% |
| Worst drawdown (1 year) | -12.4% |
| Average daily value traded | 17.94M EUR |
| Dividend yield | 2.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Iberdrola is a Spanish electric utility based in Bilbao. It generates, distributes and supplies electricity to homes, businesses and industrial customers, and it also provides related energy services. The company operates networks and power plants across Spain and several other countries, and it has built a substantial position in renewable generation, particularly wind power, alongside conventional sources. Its customers range from households to large commercial and industrial users.
On this site Iberdrola S.A. appears as a stock on the London Exchange (UK), code 0HIT, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Iberdrola S.A. (0HIT) trades on the London Exchange in UK. It last closed at EUR 21.58 on 23 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a fair price profile), ranking 551 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 30.1% and over the last three months it rose 3.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 8.9% | ||
| From 52-week high | -1.4% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 3.3% | ||
| 6-month return | 10.5% | ||
| 12-month return, skipping the last month | 21.1% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.4% | ||
| Liquidity | 78 · Strong | Trades actively. | |
| Average daily value traded | 17.94M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.7% |
|---|---|
| 1 month | +7.4% |
| 3 months | +3.3% |
| 6 months | +10.5% |
| 1 year | +30.1% |
| 3 years | +132.0% |
| 5 years | +162.5% |
Signals
| 50-day / 200-day average | 20.37 / 19.82 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.55 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2026 | EUR 0.3459 |
| 21 May 2026 | EUR 0.0041 |
| 12 Jan 2026 | EUR 0.2049 |
| 4 Jul 2025 | EUR 0.3313 |
| 22 May 2025 | EUR 0.0041 |
| 10 Jan 2025 | EUR 0.1871 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.